Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR-Preserved Trial
Stefan D. Anker(Bayer (Germany)), Milton Packer(Baylor University Medical Center), Michael Böhm(Saarland University), Dragoş Vinereanu(Carol Davila University of Medicine and Pharmacy), Dong‐Ju Choi(Inserm), Martina Brueckmann, Piotr Ponikowski(Wroclaw Medical University), Javed Butler(Jackson Memorial Hospital), Gerasimos Filippatos(National and Kapodistrian University of Athens), Eduardo Chuquiure‐Valenzuela(Inserm), Stuart Pocock(London School of Hygiene & Tropical Medicine), Sergio V. Perrone(Inserm), Sven Schnaidt(Inserm), Stefano Taddei(University of Pisa), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Marie‐France Seronde(Centre Hospitalier Universitaire de Besançon), James L. Januzzi(Harvard University), Ileana L. Piña(American Heart Association), José Ramón González‐Juanatey(Centro de Investigación en Red en Enfermedades Cardiovasculares), Muhammad Shahzeb Khan(University of Mississippi Medical Center), Stephen J. Nicholls(Australian Centre for Heart Health), Edimar Alcides Bocchi(Universidade de São Paulo), Hans‐Peter Brunner‐La Rocca(Inserm), Michele Senni(Inserm), Stefan Janssens(Maastricht University), Juan Esteban Gómez‐Mesa(Inserm), Janet Schnee(Boehringer Ingelheim (United States)), Iain Squire(University of Leicester), Nadia Giannetti(Inserm), Vijay Chopra(Max Super Speciality Hospital), Subodh Verma(St. Michael's Hospital), Béla Merkely(Semmelweis University), Hiroyuki Tsutsui(Juntendo University), Jian Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), João Pedro Ferreira(Inserm), Jindřich Špinar(University Hospital Brno), David Sim(Inserm), Waheed Jamal(Inserm)
Cited by 135
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k